Evidence map›Paper›PMID 25299071›Full record

ArticlePloS one2014

Dimerization capacities of FGF2 purified with or without heparin-affinity chromatography.

Natalia Platonova, Géraldine Miquel, Liang-Yuan Chiu, Said Taouji, Elisabetta Moroni, Giorgio Colombo, Eric Chevet, Shih-Che Sue, Andreas Bikfalvi

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 3 countries.

Natalia PlatonovaINSERM U1029, Allée Geoffroy St. Hilaire, Pessac, France; Université Bordeaux I, Allée Geoffroy St. Hilaire, Pessac, France.
Géraldine MiquelINSERM U1029, Allée Geoffroy St. Hilaire, Pessac, France; Université Bordeaux I, Allée Geoffroy St. Hilaire, Pessac, France.
Liang-Yuan ChiuInstitute of Bioinformatics and Structure Biology, National Tsing Hua University, Hsinchu, Taiwan.
Said TaoujiINSERM U1053, Team Avenir, Bordeaux, France.
Elisabetta MoroniIstituto di Chimica del Riconoscimento Molecolare, CNR, Milano, Italy.
Giorgio ColomboIstituto di Chimica del Riconoscimento Molecolare, CNR, Milano, Italy.
Eric ChevetINSERM U1053, Team Avenir, Bordeaux, France.
Shih-Che SueInstitute of Bioinformatics and Structure Biology, National Tsing Hua University, Hsinchu, Taiwan.
Andreas BikfalviINSERM U1029, Allée Geoffroy St. Hilaire, Pessac, France; Université Bordeaux I, Allée Geoffroy St. Hilaire, Pessac, France.
Université de Bordeaux · FRFondation de l'Avenir · FRInstitute of Chemistry of Molecular Recognition · ITNational Tsing Hua University · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fibroblast growth factor-2 (FGF2) is a pleiotropic growth factor exhibiting a variety of biological activities. In this article, we studied the capacity of FGF2 purified with or without heparin affinity chromatography to self-associate. Analyzing the NMR HSQC spectra for different FGF2 concentrations, heparin-affinity purified FGF2 showed perturbations that indicate dimerization and are a higher-order oligomerization state. HSQC perturbation observed with different FGF2 concentrations revealed a heparin-binding site and two dimer interfaces. Thus, with increasing protein concentrations, FGF2 monomers make contacts with each other and form dimers or higher order oligomers. On the contrary, FGF2 purified with ion-exchange chromatography did not show similar perturbation indicating that self-association of FGF2 is eliminated if purification is done without heparin-affinity chromatography. The HSQC spectra of heparin-affinity purified FGF2 can be reproduced to some extent by adding heparin tetra-saccharide to ion exchange chromatography purified FGF2. Heparin-affinity purified FGF2 bound to acceptor and donor beads in a tagged form using His-tagged or GST-tagged proteins, also dimerized in the AlphaScreen™ assay. This assay was further validated using different experimental conditions and competitors. The assay constitutes an interesting tool to study dimerization of other FGF forms as well.

Indexed as

Protein MultimerizationBinding SitesCell LineChromatography, AffinityFibroblast Growth Factor 2HeparinHumansNuclear Magnetic Resonance, BiomolecularProtein BindingReceptors, Fibroblast Growth FactorFibroblast Growth Factor 2HeparinReceptors, Fibroblast Growth Factor

Identifiers

PMID25299071
PMCPMC4192534
OpenAlexW2072194574

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.